FDA Inspection
Dabur India LimitedDabur India Limited – FDA Inspection, Jan 16, 2026
Record Details
This FDA Inspection record concerns Dabur India Limited, with an inspection on January 16, 2026, issued by the Office of Inspections and Investigations, covering human drugs.
View Company Profile
ID · 7a91ddc6-9ae6-4872-9982-9cc13d35c29c
Inspection Facts
Official Action Indicated (OAI)
Significant objectionable conditions were found and regulatory or administrative action is recommended.
- Inspection number
- 1299974
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
- Outcome
- Form 483 issued
FDA Citations
7- 21 CFR 211.100(a)Absence of Written Procedures
- 21 CFR 211.180(e)(1)Review of representative number of batches
- 21 CFR 211.192Quality control unit review of records
- 21 CFR 211.22(a)Authority lacking to review records, investigate errors
- 21 CFR 211.56(a)Sanitation--buildings not clean, free of infestation
- 21 CFR 211.65(a)Equipment construction - reactive surfaces
- 21 CFR 211.67(b)(5)Cleaning SOPs/equipment protection
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Dabur India Limited
2| Date | Classification | Office | Project area |
|---|---|---|---|
| December 6, 2019 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| October 14, 2016 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Dabur India Limited
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.